KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Non-Current Assets (2016 - 2025)

Globus Medical's Non-Current Assets history spans 15 years, with the latest figure at $3.2 billion for Q4 2025.

  • For Q4 2025, Non-Current Assets rose 3.34% year-over-year to $3.2 billion; the TTM value through Dec 2025 reached $12.6 billion, up 2.37%, while the annual FY2025 figure was $3.2 billion, 3.34% up from the prior year.
  • Non-Current Assets reached $3.2 billion in Q4 2025 per GMED's latest filing, roughly flat from $3.2 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $3.4 billion in Q3 2023 to a low of $923.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $2.1 billion, with a median of $2.0 billion recorded in 2022.
  • Peak YoY movement for Non-Current Assets: soared 225.46% in 2023, then fell 11.9% in 2024.
  • A 5-year view of Non-Current Assets shows it stood at $1.1 billion in 2021, then grew by 0.0% to $1.1 billion in 2022, then soared by 190.15% to $3.2 billion in 2023, then fell by 3.03% to $3.1 billion in 2024, then grew by 3.34% to $3.2 billion in 2025.
  • Per Business Quant, the three most recent readings for GMED's Non-Current Assets are $3.2 billion (Q4 2025), $3.2 billion (Q3 2025), and $3.2 billion (Q2 2025).